Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: Report from the Radiation Therapy Oncology Group

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 2, 2005, Pages 318-327

  Chakravarti, Arnab ^a   Seiferheld, Wendy ^b   Tu, Xiaoyu ^c   Wang, Huijun ^c   Zhang, Hua Zhong ^c   Ang, K Kian ^c   Hammond, Elizabeth ^d   Curran Jr , Walter ^e   Mehta, Minesh ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d LDS HOSPITAL   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f University of Wisconsin Health   (United States)

Author keywords

Epidermal growth factor receptor; Glioblastoma multiforme; Prognostic value; Radiotherapy

Indexed keywords

ANTIBODIES; CELLS; DIAGNOSIS; HISTOLOGY; IMMUNOLOGY; MEDICAL IMAGING; ONCOLOGY; PATIENT TREATMENT; PROTEINS; TISSUE;

ARCHIVAL TISSUES; PROGNOSTIC SIGNIFICANCE; PROTEIN EXPRESSION LEVELS; TOTAL EPIDERMAL GROWTH;

RADIOTHERAPY;

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STAINING; SURVIVAL; TISSUE MICROARRAY;

BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; NEOPLASM PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 18944393158     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.10.037     Document Type: Article

References (56)

1. E.A. Maher, F.B. Furnari, R.M. Bachoo Malignant glioma Genetics and biology of a grave matter Genes Dev 15 2001 1311 1333
2. K. Ang, B. Berkey, X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356
3. J. Baselga Why the epidermal growth factor receptor? The rationale for cancer therapy Oncologist 7 Suppl. 4 2002 2 8
4. J. Baselga Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer A promising strategy ready for clinical testing Ann Oncol 13 2002 8 9
5. J. Baselga, J. Albanell Targeting epidermal growth factor receptor in lung cancer Curr Oncol Rep 4 2002 317 324
6. N. Balaban, J. Moni, M. Shannon The effect of ionizing radiation on signal transduction Antibodies to EGF receptor sensitize A431 cells to radiation Biochim Biophys Acta 1314 1996 147 156
7. J.A. Bonner, K.P. Raisch, H.Q. Trummell Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers J Clin Oncol 18 2000 47s 53s
8. J.A. Bonner, J. De Los Santos, H.W. Waksal Epidermal growth factor receptor as a therapeutic target in head and neck cancer Semin Radiat Oncol 12 2002 11 20
9. A. Chakravarti, J.S. Loeffler, N.J. Dyson Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through the continued activation of phosphoinositide 3-kinase signaling Cancer Res 62 2002 200 207
10. A. Chakravarti, A. Chakladar, M.A. Delaney The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a ras-dependent manner Cancer Res 62 2002 4307 4315
11. F. Ciardiello, R. Caputo, R. Bianco Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide J Natl Cancer Inst 90 1998 1087 1094
12. F. Ciardiello, R. Bianco, V. Damiano Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells Clin Cancer Res 6 2000 3739 3747
13. P. Dent, D.B. Reardon, J.S. Park Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death Mol Biol Cell 10 1999 2493 2506
14. J.R. Grandis, Q. Zeng, S.D. Drenning Epidermal growth factor receptor--Mediated stat3 signaling blocks apoptosis in head and neck cancer Laryngoscope 110 2000 868 874
15. M. Hidalgo, L.L. Siu, J. Nemunaitis Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies J Clin Oncol 19 2001 3267 3279
16. S.M. Huang, J.M. Bock, P.M. Harari Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck Cancer Res 59 1999 1935 1940
17. S.M. Huang, P.M. Harari Epidermal growth factor receptor inhibition in cancer therapy Biology, rationale and preliminary clinical results Invest New Drugs 17 1999 259 269
18. S.-M. Huang, P.M. Harari Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis Clin Cancer Res 6 2000 2166 2174
19. L. Milas, K. Mason, N. Hunter In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody Clin Cancer Res 6 2000 701 708
20. D. O'Rourke, G.D. Kao, N. Singh Conversion of a radio-resistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells Proc Natl Acad Sci USA 95 1998 10842 10847
21. R.K. Schmidt-Ullrich, R.B. Mikkelsen, P. Dent Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tryosine phosphorylation Oncogene 15 1997 1191 1197
22. R.K. Schmidt-Ullrich, K. Valerie, P.B. Fogleman Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous cell epithelial cells Radiat Res 145 1996 79 83
23. N. Shinojima, K. Tada, S. Shiraishi Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res 63 2003 6962 6970
24. F.G. Barker, M.L. Simmons, S.M. Chang EGFR overexpression and radiation response in glioblastoma multiforme Int J Radiat Oncol Biol Phys 51 2001 410 418
25. A. Arslantas, S. Artan, U. Oner The importance of genomic copy number changes in the prognosis of glioblastoma multiforme Neurosurg Rev 27 2004 58 64
26. A. Chakravarti, M.A. Delaney, E. Noll Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas Clin Cancer Res 7 2001 2387 2395
27. M.-C. Etienne, J.-L. Formento, C. Lebrun-Frenay Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome Clin Cancer Res 4 1998 2383 2390
28. M.M. Feldkamp, P. Lala, N. Lau Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens Neurosurgery 45 1999 1442 1453
29. S. Leenstra, N.T. Oskam, E.H. Buleveld Genetic subtypes of human malignant astrocytoma correlate with survival Int J Cancer 79 1998 159 165
30. M.L. Simmons, K. Lamborn, M. Takahashi Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients Cancer Res 61 2001 1122 1128
31. J.S. Smith, I. Tachibana, S.M. Passe PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 2001 1246 1256
32. A. Zhu, J. Shaeffer, S. Leslie Epidermal growth factor receptor An independent predictor of survival in astrocytic tumors given definitive radiation Int J Radiat Oncol Biol Phys 34 1996 809 815
33. G. Giaccone, R. Herbst, C. Manegold Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer A phase III trial--INTACT 1 J Clin Oncol 22 2004 777 784
34. R. Herbst, G. Giaccone, J.H. Schiller Gefitinib in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer a phase III trial--INTACT2 J Clin Oncol 22 2004 785 794
35. C. Sweeney, D. Fambrough, C. Huard Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors J Biol Chem 276 2001 22685 22698
36. P.O. Hackel, E. Zwick, N. Prenzel Epidermal growth factor receptors Critical mediators of multiple receptor pathways Curr Opin Cell Biol 11 1999 184 189
37. J. Schlegel, G. Durchschlag, G. Piontek Activation of the phosphatidylinositol-3′-kinase/protein kinase B-dependent antiapoptotic pathway plays an important role in the development of radioresistance of human glioma cells Ann NY Acad Sci 973 2002 224 227
38. J. Schlegel, G. Piontek, B. Budde The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme Cancer Lett 158 2000 103 108
39. J. Schlegel, G. Piontek, H.D. Mennel Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo Anticancer Res 22 2002 2837 2840
40. E. Zwick, P.O. Hackel, N. Prenzel The EGF receptor as central transducer of heterologous signaling systems Trends Pharmacol Sci 20 1999 408 412
41. P. Dent, A. Yacoub, J. Contessa Stress and radiation-induced activation of multiple intracellular signaling pathways Radiat Res 159 2003 283 300
42. P.M. Harari, S.-M. Huang Combining EGFR inhibitors with radiation or chemotherapy Will pre-clinical studies predict clinical results? Int J Radiat Oncol Biol Phys 58 2004 976 983
43. P.M. Harari, S.M. Huang Epidermal growth factor receptor modulation of radiation response Preclinical and clinical development Semin Radiat Oncol 12 2002 21 26
44. A. Chakravarti, G. Zhai, Y. Suzuki The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas J Clin Oncol 22 2004 1926 1933
45. M. Prados, S. Chang, E.C. Burton Phase I study of OSI-774 alone or with temozolomide in patients with malignant glioma Proc Am Soc Clin Oncol 22 2003 99
46. J. Rich, D.A. Reardon, T.S. Peery Phase II trial of gefitinib in recurrent glioblastoma J Clin Oncol 22 2004 133 142
47. F.S. Lieberman, T. Cloughesy, M. Malkin Phase I-II study of ZD-1839 for recurrent malignant gliomas and meningiomas progressing after radiation therapy Proc Am Soc Clin Oncol 22 2003 105
48. W.J. Curran, C.B. Scott, J. Horton Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
49. D. Schoenfeld The asymptotic properties of nonparametric tests for comparing survival distributions Biometrika 68 1981 316 319
50. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
51. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chem Rep 5 1966 163 170
52. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 229
53. N.G. Rainov, K.U. Dobberstein, H. Bahn Prognostic factors in malignant glioma Influence of the overexpression of oncogene and tumor-suppressor gene products on survival J Neurooncol 35 1997 13 28
54. C. Bovier-Labit, O. Chinot, C. Ochi Prognostic significance of Ki67, p53, and epidermal growth factor receptor immunostaining in human glioblastomas Neuropathol Appl Neurobiol 24 1998 381 388
55. E.C. Holland, J. Celestino, C. Dai Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice Nat Genet 25 2000 55 57
56. G. Choe, S. Horvath, T. Cloughesy Analysis of the phosphatidylinositol 3-kinase signaling pathway in glioblastoma patients in vivo Cancer Res 63 2003 2742 2746